Company / Profit Margin
United Therapeutics Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
41.9%
FY2025
5-year range
28.2% / 42.3%
FY2021-FY2025
Trend
+1.0%
vs FY2024
Sector context
#9 of 146
Health Care
What the data says
Among 146 Health Care companies, United Therapeutics is in the top 6% for profit margin. Profit Margin has fluctuated over the past 9 years, ranging from -7.2% in FY2019 to 44.6% in FY2016.
Based on SEC 10-K filings.
41.9% in FY2025 with a 3-year CAGR of +4.4%. Top quartile in the Health Care sector.
Remained stable around 41.9% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +4.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 6% in Health CareTop 6% of 146This company 41.9% Sector average -796.3%
▼
+105.3% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 1.0% year-over-year.
- Currently 838.2pp above the Health Care sector average.
- Peak profit margin was recorded in FY2016.
- Lowest profit margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 41.9% | +1.0% |
| FY2024 | 41.5% | -1.8% |
| FY2023 | 42.3% | +12.6% |
| FY2022 | 37.6% | +33.0% |
| FY2021 | 28.2% | - |
| FY2020 | - | - |
| FY2019 | -7.2% | -119.9% |
| FY2018 | 36.2% | -18.6% |
| FY2017 | 44.5% | -0.4% |
| FY2016 | 44.6% | +0.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026